Madrigal Pharmaceuticals(MDGL) - 2025 Q2 - Earnings Call Transcript
Madrigal Pharmaceuticals (MDGL) Q2 2025 Earnings Call August 05, 2025 08:00 AM ET Company ParticipantsTina Ventura - Chief Investor Relations OfficerBill Sibold - CEO & DirectorDavid Soergel - EVP & Chief Medical OfficerMardi Dier - EVP & CFOThomas J. Smith - Senior MD - Immunology & MetabolismEllie Merle - ED - Biotech Equity ResearchAndrea Newkirk - Biotechnolgy Equity ResearchMayank Mamtani - Senior MD & Group Head - HealthcareConference Call ParticipantsYasmeen Rahimi - Sr. Research AnalystNone - Analys ...